ASCVD
Clinical trials for ASCVD explained in plain language.
Never miss a new study
Get alerted when new ASCVD trials appear
Sign up with your email to follow new studies for ASCVD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo pill slashes 'Bad' cholesterol in High-Risk patients
Disease control CompletedThis phase 3 study tested a daily pill that combines two drugs, obicetrapib and ezetimibe, to lower LDL (bad) cholesterol in 407 adults with inherited high cholesterol (HeFH) or heart disease (ASCVD). Participants were already on maximum cholesterol-lowering therapy. The main goa…
Matched conditions: ASCVD
Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Heart scan alert: simple notification may boost cholesterol treatment in At-Risk patients
Knowledge-focused CompletedThis study looked at whether notifying both patients and their doctors about calcium found in the heart arteries (on a chest CT scan) helps more people start cholesterol-lowering therapy. The study included 233 adults with known heart or blood vessel disease who were not already …
Matched conditions: ASCVD
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC